cancer
USA

GeneCentric Therapeutics, Inc., a Research Triangle Park, N.C.-based RNA-based genomic solutions provider, acquired Select ImmunoGenomics, LLC, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs.